Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jeanne A Geyer

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Expert Opinion on Therapeutic Targets|January 31, 2003
Cyclin-dependent protein kinases as therapeutic drug targets for antimalarial drug developmentNorman C Waters, Jeanne A Geyer
Biochimica Et Biophysica Acta|September 28, 2005
Targeting malaria with specific CDK inhibitorsJeanne A Geyer, Sean T Prigge, Norman C Waters
Biochemistry|April 28, 2004
Defective DNA repair as a potential mechanism for the rapid development of drug resistance in Plasmodium falciparumRichard F Trotta, Matthew L Brown, James C Terrell, et al.
Combinatorial Chemistry & High Throughput Screening|February 22, 2005
Rational inhibitor design and iterative screening in the identification of selective plasmodial cyclin dependent kinase inhibitorsSusan M Keenan, Jeanne A Geyer, William J Welsh, et al.
Bioorganic & Medicinal Chemistry Letters|June 26, 2007
Evaluation of broad spectrum protein kinase inhibitors to probe the architecture of the malarial cyclin dependent protein kinase PfmrkCassandra L Woodard, Susan M Keenan, Lucia Gerena, et al.
Bioorganic & Medicinal Chemistry Letters|March 3, 2009
Selective inhibition of Pfmrk, a Plasmodium falciparum CDK, by antimalarial 1,3-diaryl-2-propenonesJeanne A Geyer, Susan M Keenan, Cassandra L Woodard, et al.
Molecular and Biochemical Parasitology|June 2, 2006
Identification of an effector protein and gain-of-function mutants that activate Pfmrk, a malarial cyclin-dependent protein kinaseYueqin Chen, Dayadevi Jirage, Diana Caridha, et al.
Journal of Medicinal Chemistry|October 16, 2004
A three-dimensional in silico pharmacophore model for inhibition of Plasmodium falciparum cyclin-dependent kinases and discovery of different classes of novel Pfmrk specific inhibitorsApurba K Bhattacharjee, Jeanne A Geyer, Cassandra L Woodard, et al.
Journal of Medicinal Chemistry|August 22, 2003
Oxindole-based compounds are selective inhibitors of Plasmodium falciparum cyclin dependent protein kinasesCassandra L Woodard, Zhiyu Li, April K Kathcart, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Expert Opinion on Therapeutic Targets|January 31, 2003
Cyclin-dependent protein kinases as therapeutic drug targets for antimalarial drug developmentNorman C Waters, Jeanne A Geyer
Biochimica Et Biophysica Acta|September 28, 2005
Targeting malaria with specific CDK inhibitorsJeanne A Geyer, Sean T Prigge, Norman C Waters
Biochemistry|April 28, 2004
Defective DNA repair as a potential mechanism for the rapid development of drug resistance in Plasmodium falciparumRichard F Trotta, Matthew L Brown, James C Terrell, et al.
Combinatorial Chemistry & High Throughput Screening|February 22, 2005
Rational inhibitor design and iterative screening in the identification of selective plasmodial cyclin dependent kinase inhibitorsSusan M Keenan, Jeanne A Geyer, William J Welsh, et al.
Bioorganic & Medicinal Chemistry Letters|June 26, 2007
Evaluation of broad spectrum protein kinase inhibitors to probe the architecture of the malarial cyclin dependent protein kinase PfmrkCassandra L Woodard, Susan M Keenan, Lucia Gerena, et al.
Bioorganic & Medicinal Chemistry Letters|March 3, 2009
Selective inhibition of Pfmrk, a Plasmodium falciparum CDK, by antimalarial 1,3-diaryl-2-propenonesJeanne A Geyer, Susan M Keenan, Cassandra L Woodard, et al.
Molecular and Biochemical Parasitology|June 2, 2006
Identification of an effector protein and gain-of-function mutants that activate Pfmrk, a malarial cyclin-dependent protein kinaseYueqin Chen, Dayadevi Jirage, Diana Caridha, et al.
Journal of Medicinal Chemistry|October 16, 2004
A three-dimensional in silico pharmacophore model for inhibition of Plasmodium falciparum cyclin-dependent kinases and discovery of different classes of novel Pfmrk specific inhibitorsApurba K Bhattacharjee, Jeanne A Geyer, Cassandra L Woodard, et al.
Journal of Medicinal Chemistry|August 22, 2003
Oxindole-based compounds are selective inhibitors of Plasmodium falciparum cyclin dependent protein kinasesCassandra L Woodard, Zhiyu Li, April K Kathcart, et al.
Pageof 1